drugset / Trial / NCT00929539

Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients

NCT00929539 ↗

Phase 2 Completed 496 enrolled Akros Pharma Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effect of JTT-130 on diabetes as well as the safety and tolerability of JTT-130 in obese Type 2 diabetic patients.

Timeline

Start
2009-06
Primary completion
2010-05
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject GRANOTAPIDE Small molecule — —